(S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(--)-methadone

Mark R Hutchinson1, Andrew A Somogyi

  • 1Department of Clinical and Experimental Pharmacology, University of Adelaide, Level 5, Medical School North, Frome Road, 5005, Adelaide, Australia. mark.hutchinson@adelaide.edu.au

Insights

This study reveals that while (R)-methadone provides pain relief, both (R)- and (S)-methadone enantiomers suppress immune cell proliferation in vivo, suggesting nonclassical opioid receptor involvement.

Area of Science:

  • Pharmacology
  • Immunology
  • Neuroscience

Background:

  • Methadone, a synthetic opioid, is administered as a racemic mixture.
  • Only the (R)-(--)-methadone enantiomer exhibits mu opioid receptor agonist activity.
  • In vitro studies suggest methadone affects immune function via nonclassical opioid receptors.

Purpose of the Study:

  • To investigate the stereoselectivity of methadone's analgesic and immunomodulatory effects in vivo.
  • To compare the in vivo effects of (R)-(--)-methadone, (S)-(+)-methadone, and racemic methadone on analgesia and splenocyte proliferation.

Main Methods:

  • Assessment of analgesia using the hot plate test in Balb/c mice.
  • Ex vivo evaluation of splenocyte proliferation following in vivo administration of methadone enantiomers.
  • Statistical analysis to determine the significance of observed effects compared to saline controls.

Main Results:

  • Significant analgesia was observed with racemic and (R)-(--)-methadone, but not with (S)-(+)-methadone.
  • Both (R)-(--)- and racemic methadone significantly inhibited basal splenocyte proliferation in vivo.
  • Unexpectedly, (S)-(+)-methadone induced a greater inhibition of splenocyte proliferation than (R)-(--)- and racemic methadone.

Conclusions:

  • Methadone's immune suppression in vivo is not solely mediated by classical opioid receptors.
  • Nonclassical opioid receptors, potentially at the central level, are implicated in methadone's immunomodulatory effects.
  • The observed immune suppression occurs at clinically achievable methadone doses.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...